Oudejans J[au] - Search Results

Year	Number of Results
1991	1
1994	1
1995	5
1996	5
1997	6
1998	1
1999	4
2000	4
2001	3
2002	6
2003	5
2004	2
2005	7
2006	9
2007	11
2008	8
2009	3
2010	2
2011	3
2012	6
2014	2
2015	2
2024	0

1

Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystander.

Oudejans JJ, Jiwa NM, Meijer CJ. Oudejans JJ, et al. J Pathol. 1997 Apr;181(4):353-6. doi: 10.1002/(SICI)1096-9896(199704)181:4<353::AID-PATH782>3.0.CO;2-3. J Pathol. 1997. PMID: 9196428 Review.

2

Molecular targeted therapies for diffuse large B-cell lymphoma based on apoptosis profiles.

Cillessen SA, Meijer CJ, Notoya M, Ossenkoppele GJ, Oudejans JJ. Cillessen SA, et al. Among authors: oudejans jj. J Pathol. 2010 Apr;220(5):509-20. doi: 10.1002/path.2670. J Pathol. 2010. PMID: 20087881 Review.

3

Immunohistochemical classification of B cell neoplasms.

Oudejans JJ, van der Valk P. Oudejans JJ, et al. J Clin Pathol. 2003 Mar;56(3):193. doi: 10.1136/jcp.56.3.193. J Clin Pathol. 2003. PMID: 12610096 Free PMC article. Review. No abstract available.

4

Targeted therapies; who detects the target?

Meijer GA, Oudejans JJ. Meijer GA, et al. Among authors: oudejans jj. Cell Oncol. 2005;27(3):165-7. doi: 10.1155/2005/235650. Cell Oncol. 2005. PMID: 16037636 Free PMC article. No abstract available.

5

ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.

ten Berge RL, Oudejans JJ, Ossenkoppele GJ, Meijer CJ. ten Berge RL, et al. Among authors: oudejans jj. J Pathol. 2003 May;200(1):4-15. doi: 10.1002/path.1331. J Pathol. 2003. PMID: 12692835 Review.

6

Immunophenotyping of male breast cancer.

Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, Hinrichs B, van Diest PJ. Kornegoor R, et al. Among authors: oudejans jj. Histopathology. 2012 Dec;61(6):1145-55. doi: 10.1111/j.1365-2559.2012.04330.x. Epub 2012 Sep 7. Histopathology. 2012. PMID: 22958056

7

Epstein-Barr virus and its possible role in the pathogenesis of B-cell lymphomas.

Oudejans JJ, Jiwa NM, van den Brule AJ, Meijer CJ. Oudejans JJ, et al. Crit Rev Oncol Hematol. 1997 Feb;25(2):127-38. doi: 10.1016/s1040-8428(97)00233-3. Crit Rev Oncol Hematol. 1997. PMID: 9134314 Review. No abstract available.

8

Apoptosis resistance and response to chemotherapy in primary nodal diffuse large B-cell lymphoma.

Muris JJ, Meijer CJ, Ossenkoppele GJ, Vos W, Oudejans JJ. Muris JJ, et al. Among authors: oudejans jj. Hematol Oncol. 2006 Sep;24(3):97-104. doi: 10.1002/hon.774. Hematol Oncol. 2006. PMID: 16715473 Review.

9

Inhibition of caspase 9 and not caspase 8 mediated apoptosis may determine clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.

Oudejans JJ, Muris JJ, Meijer CJ. Oudejans JJ, et al. Cell Cycle. 2005 Apr;4(4):526-8. doi: 10.4161/cc.4.4.1595. Epub 2005 Apr 8. Cell Cycle. 2005. PMID: 15876872 Review.

10

Intensified alemtuzumab-CHOP therapy for peripheral T-cell lymphoma.

Kluin-Nelemans HC, van Marwijk Kooy M, Lugtenburg PJ, van Putten WLJ, Luten M, Oudejans J, van Imhoff GW. Kluin-Nelemans HC, et al. Among authors: oudejans j. Ann Oncol. 2011 Jul;22(7):1595-1600. doi: 10.1093/annonc/mdq635. Epub 2011 Jan 6. Ann Oncol. 2011. PMID: 21212158 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year